Many UMGCC experts presented the results of their latest cancer research at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) held May 30-June 3, 2008, in Chicago. The ASCO Annual Meeting attracts more than 30,000 attendees and is considered the premier educational and scientific event in the oncology community. Presentations by UMGCC faculty included the following:
| Title: | Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients: a population-based analysis. |
|---|---|
| Author: | I. H. Zuckerman, A. J. Davidoff, E. Onukwugha, N. Pandya, J. F. Gardner, B. Seal, N. Obeidat, T. Rapp, C. D. Mullins, M. A. Choti |
| Category: | Gastrointestinal (Colorectal) Cancer - Colorectal Cancer (including liver metastases) |
| Title: | Is there evidence of diminishing disparities in treatment (tx) with adjuvant (adj) chemotherapy (Ch) among elderly (E) stage 3 colon cancer (CC) patients (pts)? An analysis of 8,374 pts from SEER-Medicare data. |
|---|---|
| Author: | A. J. Davidoff, M. A. Choti, I. H. Zuckerman, N. Obeidat, T. Rapp, E. Onukwugha, P. Sullivan, J. F. Gardner, C. D. Mullins, N. N. Hanna |
| Category: | Health Services Research |
| Title: | Predicting patterns of failure in esophageal cancer following tri-modality therapy: Why histology matters. |
|---|---|
| Author: | M. Koshy, R. Battafarano, W. Burrows, M. Krasna, B. Greenwald, H. Mannuel, M. Suntharalingam |
| Category: | Gastrointestinal (Noncolorectal) Cancer - Esophageal, Gastric, or Small Bowel Cancer |
| Title: | Disparities and trends in prostate cancer staging over time. |
|---|---|
| Author: | C. D. Mullins, V. D. Hsu, E. Onukwugha, I. H. Zuckerman, A. Hussain |
| Category: | Genitourinary Cancer - Prostate Cancer |
| Title: | Effect of elevated expression of GST-? and p53 on prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone: An analysis of RTOG trials 9003 and 9501. |
|---|---|
| Author: | K. J. Cullen, N. Nikitakis, O. Goloubeva, M. Tan, R. Taylor, L. Schumaker |
| Category: | Head and Neck Cancer |
| Title: | Phase 2 study of sunitinib in refractory thyroid cancer. |
|---|---|
| Author: | E. E. Cohen, B. M. Needles, K. J. Cullen, S. J. Wong, J. L. Wade, S. P. Ivy, V. M. Villaflor, T. Y. Seiwert, K. Nichols, E. E. Vokes |
| Category: | Head and Neck Cancer |
| Title: | Therapy (Tx) of locally advanced (LA) NSCLC in the elderly: Analysis of 6,325 patients from Surveillance, Epidemiology and End Results (SEER)-Medicare. |
|---|---|
| Author: | M. J. Edelman, M. Tang, J. F. Gardner, C. D. Mullins, B. Seal, A. J. Davidoff |
| Category: | Lung Cancer--Local-Regional and Adjuvant Therapy - Local-Regional Therapy |
| Title: | Chemotherapy (C) and survival among 21,441 elderly (E) patients (pts) with advanced (adv) NSCLC: Analysis of SEER-Medicare claim data 1997-2002. |
|---|---|
| Author: | M. Tang, A. J. Davidoff, C. D. Mullins, D. McNally, B. Seal, M. J. Edelman |
| Category: | Lung Cancer--Metastatic Lung Cancer - Metastatic Lung Cancer |
| Title : | Phase I trial of vorinostat plus bortezomib (bort) in relapsed/refractory multiple myeloma (mm) patients (pts). |
|---|---|
| Author: | A. Z. Badros, S. Philip, R. Niesvizk, O. Goloubeva, C. Harris, J. Zweibel, J. J. Wright, A. Burger, M. R. Baer, M. J. Egorin, S. Grant |
| Category: | Lymphoma and Plasma Cell Disorders - Multiple Myeloma |
| Title: | Blast cells from patients treated for secondary AML (sAML) show less P-glycoprotein (Pgp)-mediated efflux of amonafide compared to daunorubicin: Implications for therapy. |
|---|---|
| Author: | A. S. Lundberg, M. R. Baer, M. Chau, H. P. Erba, A. L. Dressel, A. M. Ajami, R. L. Capizzi |
| Category: | Developmental Therapeutics: Cytotoxic Chemotherapy - Drug Resistance |
| Title: | Expression of breast cancer resistance protein in upper gastro-intestinal cancers. |
|---|---|
| Author: | A. Bharthuar, T. Khoury, M. R. Baer, J. Black, A. Oseroff, N. Khushalani, M. M. Javle, H. Nava, R. V. Iyer |
| Category: | Gastrointestinal (Noncolorectal) Cancer - Esophageal, Gastric, or Small Bowel Cancer |
| Title: | A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15-070) in combination with docetaxel in patients with relapsed non-small cell lung cancer (NSCLC). |
|---|---|
| Author: | E. B. Haura, C. A. Williams, A. A. Chiappori, J. Adams, D. W. Northfelt, S. M. Malik, D. Van Echo, M. J. Edelman, M. Berger |
| Category: | Lung Cancer--Metastatic Lung Cancer - Metastatic Lung Cancer |